A Study to Investigate LYL797 in Adults With Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|TNBC - Triple-Negative Breast Cancer|Non-small Cell Lung Cancer|Non Small Cell Lung Cancer|Non Small Cell Lung Cancer Metastatic|Non-Small Cell Carcinoma of Lung, TNM Stage 4|Advanced Breast Cancer|Advanced Lung Carcinoma|NSCLC|NSCLC, Recurrent|NSCLC Stage IV|Relapsed Cancer|Relapse/Recurrence|Recurrent Breast Cancer|Recurrent NSCLC
Interventions: BIOLOGICAL: LYL797
Sponsor: Lyell Immunopharma, Inc.